Polychlorinated biphenyls (PCBs) are synthetic chemicals that were widely used in electrical transformers, inks, plastics, and other consumer products. A total of 209 PCB congeners can be produced depending on the number of chlorine atoms and their position on the biphenyl structure. PCBs are lipophilic and persistent in the environment and bioaccumulate in animals and humans. Although PCBs have been banned in the United States since the 1970s, they can still be measured in most U.S. residents \[[@b8-ehp0115-001490]\].

Several epidemiologic studies have reported that prenatal exposure to PCBs is associated with poorer neurodevelopment in neonates, toddlers, and school-age children ([@b24-ehp0115-001490]; [@b29-ehp0115-001490]; [@b31-ehp0115-001490], [@b30-ehp0115-001490]; [@b35-ehp0115-001490]; [@b56-ehp0115-001490]; [@b57-ehp0115-001490]). These findings are consistent with animal studies in rodents and rhesus monkeys, which found that *in utero* exposure to PCBs was related to poorer discrimination reversal learning and spatial learning ([@b38-ehp0115-001490]; [@b58-ehp0115-001490]; [@b68-ehp0115-001490]). Together with altered neuronal Ca^2+^ signaling ([@b71-ehp0115-001490]) and reduced dopamine levels ([@b59-ehp0115-001490]), disruption of thyroid hormone (TH) homeostasis, which is essential for normal brain development, has been proposed as a potential mechanism for the deleterious neurodevelopmental effects of PCBs. In animals, hypothyroidism affects neuronal proliferation, migration, myelination, and synaptogenesis ([@b27-ehp0115-001490]; [@b50-ehp0115-001490]; [@b54-ehp0115-001490]). In humans, maternal thyroid status may be of critical importance for fetal neurodevelopment ([@b25-ehp0115-001490]; [@b44-ehp0115-001490]; [@b53-ehp0115-001490]), and iodine deficiency--related hypothyroidism is a known cause of cretinism, the leading preventable cause of mental retardation worldwide ([@b22-ehp0115-001490]). Congenital hypothyroidism, associated with a variety of pathologies resulting in insufficient TH levels, can also lead to neurodevelopmental problems ([@b20-ehp0115-001490]; [@b32-ehp0115-001490]). For this reason, TH levels are routinely measured as part of neonatal screening programs so that TH supplements are administered promptly if necessary.

Several studies suggest that PCBs may disrupt TH levels. PCBs, and especially their hydoxylated metabolites (OH-PCBs), are structurally similar to thyroxine (T~4~). Some PCB congeners reportedly induce the microsomal enzyme uridinediphosphate glucuronosyltransferase (UDP-GT), which catalyzes the glucuronidation of T~4~ ([@b26-ehp0115-001490]; [@b40-ehp0115-001490]). Additionally, dioxin-like PCB congeners can bind to the aryl hydrocarbon receptor, resulting in the induction of the cytochrome P450 CYP1A1 as well as the UDP-GT isoenzyme UGT1A6 (methyl-cholanthrene-like inducers), which together with UGT1A1 is responsible for the glucuronidation of T~4~ in rats ([@b66-ehp0115-001490]). Other PCB congeners have a phenobarbital-like induction pattern which is characterized by the induction of CYP2B and UGT1A1 ([@b61-ehp0115-001490]). PCBs inducing CYP1A and CYP2B are therefore likely to also induce UDP-GT.

In animals, *in utero* exposure to PCB mixtures as well as to individual PCB congeners decreases free and total T~4~ blood levels. [@b49-ehp0115-001490] exposed rats to the commercial PCB mixture Aroclor 1254 from days 10 to 16 of gestation and found a dose-related reduction in circulating total and free T~4~ in fetuses on gestation day 20 and pups on postnatal days 4 and 21. Similar results were obtained with PCB-77 in mice ([@b17-ehp0115-001490]) and OH-PCBs in rats ([@b45-ehp0115-001490]).

Human studies suggest a relationship between PCBs and TH, but results differ depending on the PCB congeners studied, the grouping schemes used, and whether TH and PCB levels have been examined in the placenta, maternal, cord, or infant blood. For example, [@b51-ehp0115-001490] reported positive associations between PCB-118 and thyroid-stimulating hormone (TSH) both measured in children (*n* = 320) as well as negative associations between PCBs 138, 153, 180, 183, and 187, and the sum of seven congeners, and free triiodothyronine (T~3~). [@b62-ehp0115-001490] found negative associations between PCBs 138, 153, 180, and the sum of 11 congeners, and total T~3~ in 101 pregnant women, but did not find associations with TSH. In another study, the sum of PCB congeners measured in 160 maternal serum and breast milk samples was not associated with cord blood total T~4~, free T~4~, or TSH levels ([@b41-ehp0115-001490]). [@b55-ehp0115-001490] measured seven PCB congeners (28, 52, 101, 118, 138, 153, and 180) in 70 cord blood samples and found no significant association of their individual or summed concentrations with TSH in 3-day-olds. In the only study to measure TSH in neonates in relation to maternal PCB exposure, [@b34-ehp0115-001490] reported significant positive correlations between the nonplanar PCB toxic equivalent (TEQ) measured in breast milk and TSH levels in 2-week-olds and between the planar PCB TEQ, the dioxin TEQ, and the PCB--dioxin TEQ, and infant TSH levels at 2 weeks and 3 months of age.

Animal studies suggest that PCB congeners differ in their mechanisms of action and in their toxicologic potencies ([@b19-ehp0115-001490]; [@b33-ehp0115-001490]; [@b39-ehp0115-001490]) leading some researchers to develop mechanism-based congener groupings. One such grouping is based on congeners' dioxin-like properties using a method to weigh them by their toxic equivalencies relative to 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD) ([@b65-ehp0115-001490]). [@b69-ehp0115-001490] proposed three groups of PCB congeners based on potential mechanisms of action, structure--activity considerations as well as occurrence in house dust and human samples: Group 1 included PCB congeners that are potentially estrogenic; group 2 included congeners that are potentially antiestrogenic, immunotoxic, and dioxin-like; and group 3 included microsomal enzyme inducers. To date, PCB congeners have not been grouped based on their potential to disrupt TH homeostasis.

Although other mechanisms may be involved, current evidence seems to support the hypothesis that the reduced T~4~ levels caused by PCBs in animals occurs at least in part through the induction of UDP-GT. An increase in biliary T~4~--glucuronide excretion has been reported following treatment of rodents with PCBs ([@b3-ehp0115-001490]). Furthermore, administration of Aroclor 1254 to thyrodectomized rats implanted with osmotic pumps delivering T~4~ resulted in a reduction of total T~4~ and free T~4~ by 75% and 70%, respectively, supporting an extrathyroidal mechanism of action ([@b2-ehp0115-001490]). Among all UDP-GT inducers tested in the study, UDP-GT activity was negatively correlated with serum total and free T~4~ levels, supporting the hypothesis that induction of this microsomal enzyme contributes to the PCB-related reduction in circulating TH levels.

The purpose of the present investigation is twofold: to group PCB congeners based on their potential to induce microsomal enzymes in animals; and to examine the relation between neonatal TSH and prenatal exposure to PCB congeners grouped according to their structure and potential mechanisms of actions.

Methods
=======

Participants
------------

Data for this study were collected as part of the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS), a longitudinal birth cohort study investigating environmental exposures and the health of pregnant women and children residing in the agricultural Salinas Valley, California. Pregnant women planning to deliver at Natividad Medical Center (NMC), a county hospital located in Salinas, California, and receiving prenatal care in this hospital or at one of five clinics of Clinica de Salud del Valle de Salinas were screened for enrollment between October 1999 and October 2000. Women were eligible to participate if they were ≥18 years of age, had completed \< 20 weeks gestation, spoke English or Spanish, and were MediCal eligible. A total of 601 women agreed to participate in the study, resulting in 538 live births. Excluded from these analyses were participants with insufficient serum volume for PCB analyses (*n* = 118), no locatable TSH data or only diagnostic information (*n* = 111), missing neonatal age at the time of blood draw (*n* = 22), and twins (*n* = 2). Women included in analyses (*n* = 285) were similar to those excluded except in that they had spent less time in the United States than excluded women. This study was approved by the University of California, Berkeley, Committee for the Protection of Human Subjects. All participants gave written informed consent before inclusion in the study.

Interviews
----------

Participants were interviewed during pregnancy as well as shortly after delivery in English or Spanish by bilingual, bicultural staff. Sociodemographic information collected included maternal age, family income, the number of people supported by this income, country of birth, and number of years lived in the United States. Information on alcohol, tobacco, drug, and caffeine consumption as well as agricultural work was also collected.

Measurement of neonatal TSH
---------------------------

TSH is routinely measured by the California Department of Health Services Genetic Diseases Branch as part of the state's Neonatal Screening Program. Samples were collected by heel stick and deposited on a filter paper, which was left to dry at room temperature. Dried blood spots were then analyzed with a solid-phase, time-resolved sandwich fluoroimmunoassay (AutoDELFIA; PerkinElmer, Wellesley, MA) using a lanthanide metal europium (Eu) label. These data were abstracted from medical records. On average, blood spot samples were collected 25 hr after birth (range, 4--121 hr).

Measurement of PCBs in maternal serum
-------------------------------------

Blood samples were collected by venipuncture at the end of the second trimester (mean ± SD gestational age = 26.1 ± 2.9 weeks) and shortly before delivery. Delivery samples were only included in the few cases when the second-trimester sample was not collected (*n* = 19). Samples were processed at NMC and stored at −80°C until shipment on dry ice to the CDC in Atlanta, Georgia, for analysis. We measured a total of 34 PCB congeners (International Union for Pure and Applied Chemistry nos. 18, 28, 44, 49, 52, 66, 74, 87, 99, 101, 118, 128, 138, 146, 149, 151, 153, 156, 157, 167, 170, 172, 177, 178, 180, 183, 187, 189, 194, 195, 196, 199, 206, 209) by high-resolution gas chromatography/high-resolution mass spectrometry with isotope dilution quantification based on methods previously published ([@b1-ehp0115-001490]). Quality control samples were included in each run. Simple substitution methods, which consist of assigning values when measurements are below the limit of detection (LOD) such as LOD/2 or LOD/√2, may bias results when detection frequencies are \< 90--95% ([@b43-ehp0115-001490]). Values below the LOD were therefore randomly imputed from a log-normal distribution whose parameters were determined by maximum likelihood estimation. This method generally produces unbiased parameter estimates ([@b43-ehp0115-001490]). LODs for PCBs ranged between 0.01 and 1.92 ng/g lipids. Statistical analyses were restricted to PCB congeners with a detection frequency \> 75% and included PCBs 18, 28, 44, 49, 52, 66, 74, 99, 101, 118, 138, 146, 153, 156, 180, 183, 187, 194, and 199.

Triglycerides and total cholesterol were determined using standard enzymatic methods (Roche Chemicals, Indianapolis, IN). Total blood lipid concentrations were then calculated using the method reported by [@b52-ehp0115-001490]. PCB values were lipid-adjusted for all analyses by dividing serum PCB concentrations by total blood lipid concentrations.

PCB groupings
-------------

PCB congeners were grouped according to previously proposed structure-based and mechanism-based groupings ([@b65-ehp0115-001490]; [@b69-ehp0115-001490]). Structure-based groupings were generated by summing the individual levels of mono-*ortho* (PCBs 28, 66, 74, 118, 156, 157, 167, and 189) and di-*ortho* substituted (PCBs 18, 44, 49, 52, 87, 99, 101, 128, 138, 146, 153, 172, 180, and 194) PCBs. The mechanism-based methods included the three groupings proposed by [@b69-ehp0115-001490] and the TEQ method. We calculated TEQs using the World Health Organization's toxic equivalency factors (TEFs) ([@b65-ehp0115-001490]). In addition, we created *a priori* another mechanism-based grouping of PCBs according to their ability to induce UPD-GT, CYP1A \[or 7-ethoxyresorufin-*O*-deethylase (EROD)\] and CYP2B \[or 7-pentoxyresorufin-*O*-dealkylase (PROD)\] in mammals. PCB congeners likely to induce these enzymes were identified through a search in PubMed (<http://www.ncbi.nlm.nih.gov/sites/entrez>) and through referenced articles ([Table 1](#t1-ehp0115-001490){ref-type="table"}). PCB congeners were considered enzyme inducers if a continuous linear or nonlinear dose response could be identified without otherwise overt toxic effects. Doses necessary to induce microsomal enzymes vary among animal species and strains tested ([@b4-ehp0115-001490]). We considered a dose--response relationship in at least one strain for UDP-GT, CYP1A, or CYP2B as an indication of possible UDP-GT induction in humans. PCB congeners in the final grouping included PCBs 52, 99, 101, 118 153, 156, 157, 167, 180, 183, 187, 189, 194, and 199. Because dioxin-like PCBs induce CYP1A, the enzyme inducers grouping included these congeners.

Statistical analyses
--------------------

We used Pearson's correlations to evaluate the interrelationship of PCB congeners. We then used one-way analysis of variance (ANOVA) to compare PCB levels by demographic characteristics. We constructed multiple linear regression models to test the association of both individual PCB congeners as well as PCB groupings with neonatal TSH levels. Covariates considered in regression models included (categorized as shown in [Table 2](#t2-ehp0115-001490){ref-type="table"} or as indicated below): maternal age (continuously), race, country of birth, marital status (married or not), years of education, prepregnancy body mass index (BMI; continuously); cigarette, alcohol, and caffeine consumption during pregnancy (none vs. any); gestational age at time of blood collection for PCB analysis (continuously); and neonate's birth weight (continuously), sex, gestational age at birth (continuously), birth order (continuously), and age (in hours) at the time of heel stick (continuously). Covariates were selected for final models if they were related with the outcome (*p* \< 0.20); final models included neonatal age at the time of heel stick, gestational age at birth, infant birth weight, sex, and mother's prepregnancy BMI.

We also considered the potential confounding effect of other environmental chemicals such as lead, organophosphate pesticides, and other organochlorine compounds including *o,p*′-dichlorodiphenyltrichloroethane (DDT), *p,p*′-DDT, *p,p*′-dichlorodiphenyl-trichloroethylene (DDE), β- and γ-hexachloro-cyclohexane, dieldrin, hexachlorobenzene, heptachlor epoxide, mirex, oxychlordane, and *trans*-nonachlor. Organochlorine compounds were measured concurrently with PCBs using the method described above and were lipid-adjusted. We determined exposure to organophosphate pesticides by averaging the concentration of dialkyl phosphate metabolites measured in urine by high-resolution gas chromatography--tandem mass spectrometry with isotope dilution quantification; these samples were collected twice during pregnancy (mean gestational age, 13 and 26 weeks) ([@b5-ehp0115-001490]; [@b6-ehp0115-001490]; [@b23-ehp0115-001490]). We measured lead in maternal and cord blood using graphite furnace atomic absorption spectrophotometry.

TSH levels surge at birth and decrease sharply within the first days of life, the period during which blood was collected for TSH analysis. Neonate's age at the time of blood collection (expressed in hours) was negatively associated with both PCBs and TSH in our data. Log~10~(age) maximized the correlation between age at the time of blood collection and log~10~(TSH) and was entered as such in the models (*r* = −0.6, *p* \< 0.001). As an alternative, we also age-standardized TSH levels based on data obtained from the neonatal screening program administered by the Genetics Disease Branch of the California Department of Health (<http://www.dhs.ca.gov/pcfh/gdb/html/NBS/>) (*n* = 1,330,213).

The concentrations of the different PCB congeners are usually highly intercorrelated, so the association of a specific grouping with neonatal TSH may be attributed to uncontrolled confounding by PCB congeners not included in models. Therefore, we also included the sum of those PCB congeners that were not part of any particular grouping in each model.

As described above, we ran multiple models to examine associations of neonatal TSH with individual PCB congeners. The Bonferroni adjustment method may be too conservative when a large number of tests are carried out. We therefore used the bootstrap-based single-step maxT multiple testing procedure proposed by [@b21-ehp0115-001490], which adjusts for multiple hypothesis testing while accounting for the correlation between exposures by estimating the joint distribution of test statistics (multtest package in R; R Foundation for Statistical Computing, Vienna, Austria).

Adding congeners assumes an equal potency for every component of a given grouping, which may not be appropriate. Thus, we also analyzed the data by using principal-component analysis to summarize both the group of enzyme inducers and congeners that have not been identified as enzyme inducers. Scores for each group's first component (defined as the loadings-weighted sum of PCB congeners) were then entered as the independent variable in a multiple linear regression model along with the covariates identified above.

Missing values for PCB congeners were imputed based on a nearest neighbor (Euclidian distance) method (impute package in R). Values for environmental exposures (including PCBs) and TSH were expressed on the log~10~ scale for statistical analyses. Analyses were performed with Intercooled STATA, version 8.1 (StataCorp., College Station, TX) and R, version 2.3.0 (R Foundation for Statistical Computing, Vienna, Austria).

Results
=======

Most participating women were young, Latina, born in Mexico, and had little education ([Table 2](#t2-ehp0115-001490){ref-type="table"}). Almost all spoke Spanish at home (94%), and most were below the federal poverty line (61%) and had at least one household member working in agriculture (76%). There were slightly more male than female children (52 vs. 48%). Approximately 3% of the newborns had a low birth weight (\< 2,500 g), and 8% were premature (\< 37 weeks gestation).

TSH levels were within the reference range for all children (≤25 mIU/L) with a geometric mean of 5.7 mIU/L \[95% confidence interval (CI), 5.3 to 6.1\]. Gestational age at birth and birth weight were positively associated with TSH levels (data not shown). No other covariates were related to TSH levels.

The sum of those PCB congeners with a detection frequency \> 75% increased with maternal age (*p* \< 0.001) and with the number of years of education (*p* \< 0.05; [Table 3](#t3-ehp0115-001490){ref-type="table"}). Levels were also higher in women who smoked during pregnancy, but the difference was not statistically significant.

Only PCBs 183 (β= 0.11; 95% CI, 0.02 to 0.20) and 199 (β= 0.10; 95% CI, 0.01 to 0.20) were significantly positively related to neonatal TSH levels in univariate regressions (data not shown); however, as shown in [Table 4](#t4-ehp0115-001490){ref-type="table"}, 6 of the 19 PCB congeners detected in \> 75% of the samples---namely PCBs 101, 180, 183, 187, 194, and 199---were found to be significantly related to TSH levels, after adjustment for neonatal age at the time of blood draw (β= 0.08--0.14, *p* \< 0.05). Three additional congeners, PCBs 99, 138, and 153, were significantly positively related to TSH after adjustment for all covariates (PCB-99: β = 0.11; 95% CI, 0.02 to 0.21; PCB-138: β = 0.09; 95% CI, 0.01 to 0.18 and PCB-153: β = 0.08; 95% CI, 0.00 to 0.17).

PCBs 194 and 199 remained significantly associated with TSH levels after adjustment for multiple hypothesis testing (PCB-194: β = 0.12; 95% CI, 0.01 to 0.24; PCB-199: β = 0.14; 95% CI, 0.02 to 0.25), whereas PCBs 101, 183, and 187 almost reached statistical significance (PCB-101: β = 0.09; 95% CI, −0.01 to 0.18; PCB-183: β = 0.13; 95% CI, −0.01 to 0.23; PCB-187: β = 0.09; 95% CI, −0.01 to 0.20).

Total PCB levels, structure-based groupings (mono-*ortho* and di-*ortho* substituted PCBs), and the TEQ of dioxin-like PCBs were not significantly associated with neonatal TSH levels ([Table 4](#t4-ehp0115-001490){ref-type="table"}). However, the sum of PCBs specifically hypothesized to induce T~4~-metabolizing enzymes was positively associated with neonatal TSH levels; each 10-fold increase in the sum of enzyme-inducing PCBs was associated with a 29% (95% CI, 2 to 62%) increase in TSH (computed from [Table 4](#t4-ehp0115-001490){ref-type="table"}). The association was linear on a log--log scale, as shown in [Figure 1](#f1-ehp0115-001490){ref-type="fig"}. Including the sum of PCBs not found to be enzyme inducers in the same model or removing extreme values did not materially alter results (data not shown). The principal-component analysis--computed factor summarizing the serum level of potential enzyme inducers (accounting for 64% of the variance) was also significantly associated with neonatal TSH (β= 0.015, 95% CI, 0.005 to 0.024), whereas the factor representing noninducers (accounting for 63% of the variance) was not (β= 0.006, 95% CI, −0.005 to 0.017). Furthermore, the sum of congeners included in group 3 of the classification proposed by [@b69-ehp0115-001490], which is also based on enzyme induction, was significantly associated with TSH levels (β= 0.11; 95% CI, 0.02 to 0.20). The fact that we found a significant association with the sum of all potential enzyme inducer PCBs but not with the TEQ suggests that CYP2B inducers were primarily associated with TSH. This was confirmed when we grouped PCBs by specific enzyme induced (CYP2B/PROD inducers: β = 0.11; 95% CI, 0.01 to 0.21).

Results above were similar whether neonate's age at the time of TSH measurement was controlled for by including the variable as a covariate in models or by standardizing with the use of an external population (California Department of Health Services, Genetic Diseases Branch). The method used to account for blood lipids (including it as a covariate or expressing PCBs on a lipid basis) did not appreciably alter results.

Discussion
==========

Results from this study suggest that prenatal exposure to PCB congeners that induce CYP2B in animals is positively associated with TSH levels in children shortly after birth. In animals, UDP-GT (UGT1A1) is induced concurrently with CYP2B following exposure to phenobarbital-like compounds, which may explain the observed association ([@b61-ehp0115-001490]). However, we found no association between levels of TSH and total PCBs, PCBs grouped by structure (mono-and di-*ortho*--substituted PCBs), or dioxin-like PCBs (TEQ). These findings were observed in the CHAMACOS population, which had low exposure to PCBs compared with the general U.S. population ([@b8-ehp0115-001490]). The median PCB-153 concentration, for instance, was 5.6 times lower in our participants than in the NHANES (National Health and Nutritional Examination Survey) sample (5.4 vs. 30.1 ng/g lipids).

Our findings differ from those of [@b34-ehp0115-001490], who found associations between maternal dioxin-like PCBs (TEQ) and neonatal TSH levels, and of [@b67-ehp0115-001490], who reported associations between the placental dioxin/PCB TEQ and cord blood TSH levels. Although we may have underestimated the TEQ in our population because we did not measure the levels of two key dioxin-like PCBs (PCBs 126 and 169), the exposure level in the Dutch study appeared to be substantially higher (about 20 times) than in the current study ([@b42-ehp0115-001490]). Our results also differ from those of previous studies that found no association of TSH levels with individual PCB congeners ([@b55-ehp0115-001490]; [@b62-ehp0115-001490]). However, our findings are consistent with those of [@b41-ehp0115-001490], [@b62-ehp0115-001490], and [@b55-ehp0115-001490], who did not find an association between the sum of all PCB congeners measured and TSH levels in pregnant women, neonates, and cord blood. Our results also agree with the lack of association between the structure-based grouping of mono-*ortho*--substituted PCB congeners and TSH levels, as reported in two previous studies ([@b62-ehp0115-001490]; [@b67-ehp0115-001490]).

Serum concentrations of PCB congeners are highly intercorrelated, yet individual congeners may differ in their health effects and mechanisms of action. Except for a study by [@b70-ehp0115-001490], who investigated associations with breast cancer, we are not aware of any other study that grouped PCBs based on the mechanism of enzyme induction. To date, no study examining the potential of PCBs to disrupt TH has grouped congeners based on their potential to specifically disrupt TH.

One of the main strengths of this study is that we attempted to characterize *a priori* PCB congeners based on their potential to affect TH. We grouped PCBs based on evidence from animal studies suggesting the potential of specific PCB congeners to induce UDP-GT. We also considered the potential confounding effect of a large number of demographic and environmental covariates. Our findings were further supported by principal-component analysis, with the first factor summarizing enzyme-inducing congeners being significantly associated with neonatal TSH levels whereas the factor summarizing other congeners was not. Strengths also include the control for multiple hypothesis testing and our use of distribution-based imputation techniques for values below the LOD.

There are limitations to the method we propose, some of which stem from limited data. First, we could not find published data for seven of the 19 congeners commonly found in the CHAMACOS population (detection frequency \> 75%). Also, our method does not consider other potential mechanisms of action by which PCBs could affect TH levels, including the binding of PCBs to transthyretin and displacement of T~4~ ([@b9-ehp0115-001490]), increased liver T~4~ uptake and decreased pituitary sensitivity to thyroid-releasing hormone ([@b33-ehp0115-001490]), altered T~4~ and T~3~ synthesis ([@b14-ehp0115-001490]), and inhibited thyroid gland response to TSH ([@b7-ehp0115-001490]). Summing the concentrations of PCB congeners also assumes equal potencies, which may not be appropriate. Summarizing the grouping with principal-component analysis--derived factors, though avoiding the equal potencies assumption of the summation method, still assumes no synergistic effect. An ideal grouping would consider all potential mechanisms of action, different relative potencies, and interactions. One strategy to improve our method might be to develop a TEQ-like weighing system ([@b65-ehp0115-001490]). Such a scheme would require more congener-specific data and would need to consider whether a simple linear additive model appropriately represents observed effects at environmentally relevant doses.

In summary, we report a positive association between neonatal TSH levels and prenatal exposure to PCBs reported to induce microsomal enzymes (specifically CYP2B) and suspected to induce UDP-GT in animals but not with the sum of all PCB congeners, or PCBs grouped according to their dioxin-like activity or structure. This is the largest study to date investigating prenatal exposure to PCBs and neonatal TSH. If replicated, our findings would support the hypothesis that not all PCB congeners disrupt thyroid hormones, and would argue against summing all PCB congeners. However, they would support grouping PCB congeners based on their potential mechanism of action of UDP-GT induction. Our results also suggest that PCBs affect TH homeostasis even at the low background level of exposure found in the CHAMACOS population. Although TSH remained within the reference range, previous animal and human studies suggest that maternal hypothyroxinemia (low free T~4~ and normal TSH levels) during early pregnancy adversely affects neurodevelopment ([@b46-ehp0115-001490]; [@b53-ehp0115-001490]). Future studies should examine whether TH levels within the reference range in neonates may be related to neurodevelopment.
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###### 

References supporting microsomal enzyme induction by individual PCB congeners in animals.

        Microsomal enzymes                                                                                                                                                                        
  ----- --------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------
  42                                                                                                                                                                                              [@b15-ehp0115-001490]
  47                                                                                                                                                                                              [@b15-ehp0115-001490]
  52                                                                                                                                                                                              [@b15-ehp0115-001490]
  77    [@b19-ehp0115-001490]; [@b60-ehp0115-001490]; [@b66-ehp0115-001490]   [@b11-ehp0115-001490]; [@b48-ehp0115-001490]; [@b60-ehp0115-001490]                                                 
  99                                                                                                                                                                                              [@b15-ehp0115-001490]
  101                                                                                                                                                                                             [@b15-ehp0115-001490]
  105   [@b10-ehp0115-001490]                                                 [@b10-ehp0115-001490]                                                                                               [@b10-ehp0115-001490]; [@b15-ehp0115-001490]
  118                                                                         [@b11-ehp0115-001490]; [@b15-ehp0115-001490]; [@b36-ehp0115-001490]                                                 [@b15-ehp0115-001490]
  126   [@b16-ehp0115-001490]; [@b60-ehp0115-001490]; [@b63-ehp0115-001490]   [@b12-ehp0115-001490]; [@b16-ehp0115-001490]; [@b18-ehp0115-001490]; [@b60-ehp0115-001490]; [@b63-ehp0115-001490]   
  128                                                                         [@b37-ehp0115-001490]                                                                                               
  149                                                                                                                                                                                             [@b39-ehp0115-001490]
  153   [@b16-ehp0115-001490]                                                 [@b13-ehp0115-001490]; [@b18-ehp0115-001490]                                                                        [@b15-ehp0115-001490]; [@b16-ehp0115-001490]; [@b18-ehp0115-001490]; [@b28-ehp0115-001490]
  154                                                                                                                                                                                             [@b15-ehp0115-001490]
  156   [@b63-ehp0115-001490]                                                 [@b64-ehp0115-001490]                                                                                               [@b64-ehp0115-001490]
  163                                                                                                                                                                                             [@b15-ehp0115-001490]
  169   [@b47-ehp0115-001490]                                                 [@b47-ehp0115-001490]                                                                                               [@b47-ehp0115-001490]
  170                                                                                                                                                                                             [@b15-ehp0115-001490]
  180                                                                                                                                                                                             [@b15-ehp0115-001490]
  183                                                                                                                                                                                             [@b15-ehp0115-001490]
  187                                                                                                                                                                                             [@b15-ehp0115-001490]
  189                                                                                                                                                                                             [@b15-ehp0115-001490]
  194                                                                                                                                                                                             [@b15-ehp0115-001490]
  199                                                                                                                                                                                             [@b15-ehp0115-001490]

###### 

Demographic characteristics in a population of pregnant women and their children in the Salinas Valley, CA (*n* = 285).

                                                 Sum PCBs (ng/g lipids)[a](#tfn1-ehp0115-001490){ref-type="table-fn"}   
  ----------------------------------- ---------- ---------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------
  Maternal                                                                                                              
   Age (years)                                                                                                          
    18--24                            142 (50)   54.1                                                                   49.2--59.5[\*](#tfn2-ehp0115-001490){ref-type="table-fn"}[\#](#tfn3-ehp0115-001490){ref-type="table-fn"}
    25--29                            89 (31)    59.9                                                                   53.1--67.5
    30--34                            35 (12)    72.9                                                                   60.2--88.3
    35--45                            19 (7)     87.5                                                                   72.3--105.9
   Race                                                                                                                 
    White                             3 (1)      38.9                                                                   9.7--156.3
    Latina                            275 (96)   59.9                                                                   55.9--64.2
    Other                             7 (2)      67.3                                                                   50.2--90.3
   Education                                                                                                            
    ≤6th grade                        118 (41)   55.7                                                                   50.1--62.0[\#](#tfn3-ehp0115-001490){ref-type="table-fn"}
    7--12th grade                     100 (35)   59.4                                                                   53.0--66.5
    ≥High school                      67 (23)    68.5                                                                   60.1--78.1
   Income (% poverty)                                                                                                   
    \< 100                            162 (61)   59.3                                                                   54.3--64.7
    100--200                          96 (36)    60.5                                                                   53.7--68.2
    \> 200                            9 (3)      49.1                                                                   29.9--80.4
   Country of birth                                                                                                     
    United States                     34 (12)    61.9                                                                   50.0--76.5
    Mexico                            244 (86)   59.8                                                                   55.6--64.3
    Other                             7 (3)      52.0                                                                   34.5--78.6
   Time in the USA (years)                                                                                              
    ≤5                                156 (55)   59.0                                                                   53.7--64.7
    6--10                             69 (24)    61.3                                                                   53.4--70.4
    ≥11                               60 (21)    60.4                                                                   52.5--69.5
   Parity                                                                                                               
    0                                 103 (36)   61.6                                                                   54.8--69.2
    ≥1                                183 (64)   58.8                                                                   54.2--63.9
   Smoking during pregnancy                                                                                             
    Yes                               12 (4)     68.7                                                                   48.5--97.3
    No                                274 (96)   59.5                                                                   55.5--63.7
  Infant                                                                                                                
   Sex                                                                                                                  
      Male                            147 (52)   58.2                                                                   52.9--63.9
     Female                           138 (48)   61.6                                                                   56.0--67.8
   Birth weight (g)                                                                                                     
     \< 2,500                         9 (3)      66.8                                                                   49.9--89.4
     2,500--3,500                     150 (52)   58.6                                                                   53.3--64.4
     \> 3,500                         126 (44)   60.8                                                                   55.0--67.2
   Gestational age at birth (weeks)                                                                                     
     \< 37                            22 (8)     61.4                                                                   49.7--75.7
     37--42                           264 (92)   59.7                                                                   55.6--64.1
     \> 42                            0 (0)      ---                                                                    ---

PCBs with a detection frequency ≥75% were summed.

*p* \< 0.05 ANOVA.

*p* \< 0.05 linear trend by Pearson's correlation.

###### 

PCB levels (geometric means), detection frequencies, ranges, and LOD ranges in a population of pregnant women in the Salinas Valley, CA.

                                                                      No.   LOD range      Detection frequency (%)   Geometric mean   95% CI       Range
  ------------------------------------------------------------------- ----- -------------- ------------------------- ---------------- ------------ --------------
  ∑PCBs[a](#tfn4-ehp0115-001490){ref-type="table-fn"} (ng/g)          285   0.02--1.92     100                       59.8             56.0--64.0   15.3--323.7
  TEQ (pg/g)                                                          285   0.004--0.086   100                       0.86             0.75--0.97   \< LOD--5.17
  Inducers[b](#tfn5-ehp0115-001490){ref-type="table-fn"} (ng/g)       285   0.03--1.44     100                       38.9             36.3--41.6   10.0--250.3
  Mono-*ortho*[c](#tfn6-ehp0115-001490){ref-type="table-fn"} (ng/g)   285   0.03--1.11     100                       29.4             27.2--31.7   6.4--127.7
  Di-*ortho*[d](#tfn7-ehp0115-001490){ref-type="table-fn"} (ng/g)     285   0.03--1.44     100                       27.6             25.9--29.5   7.3--213.1
  Wolff method                                                                                                                                     
   Group 1[e](#tfn8-ehp0115-001490){ref-type="table-fn"} (ng/g)       285   0.03--1.92     100                       8.3              7.6--9.1     0.4--62.9
   Group 2[f](#tfn9-ehp0115-001490){ref-type="table-fn"} (ng/g)       285   0.03--1.11     100                       13.2             12.3--14.1   2.1--69.1
   Group 3[g](#tfn10-ehp0115-001490){ref-type="table-fn"} (ng/g)      285   0.04--1.09     100                       8.4              7.7--9.1     0.6--138.0
  Individual congeners                                                                                                                             
   PCB-18 (ng/g)                                                      279   0.03--0.88     100                       6.5              5.9--7.1     0.9--32.1
   PCB-28 (ng/g)                                                      285   0.03--0.79     100                       17.4             15.8--19.1   3.1--91.7
   PCB-44 (ng/g)                                                      238   0.06--1.92     98.7                      2.3              2.1--2.6     \< LOD--11.4
   PCB-49 (ng/g)                                                      250   0.05--1.40     99.2                      1.5              1.4--1.7     \< LOD--7.9
   PCB-52 (ng/g)                                                      261   0.05--1.89     99.2                      3.0              2.7--3.3     \< LOD--12.4
   PCB-66 (ng/g)                                                      276   0.39--1.02     100                       2.8              2.5--3.0     0.4--16.0
   PCB-74 (ng/g)                                                      276   0.04--1.11     100                       4.1              3.8--4.4     0.7--20.8
   PCB-99 (ng/g)                                                      263   0.06--1.09     100                       1.8              1.7--1.9     0.5--11.6
   PCB-101 (ng/g)                                                     241   0.06--1.44     94.6                      0.9              0.8--1.1     \< LOD--5.8
   PCB-118 (ng/g)                                                     270   0.05--0.86     99.6                      3.4              3.2--3.7     \< LOD--4.7
   PCB-138 (ng/g)                                                     263   0.03--0.65     100                       2.5              2.3--2.7     0.2--30.9
   PCB-146 (ng/g)                                                     249   0.05--0.60     87.6                      0.5              0.4--0.5     \< LOD--14.7
   PCB-153 (ng/g)                                                     273   0.04--0.70     100                       5.6              5.2--6.0     0.3--95.6
   PCB-156 (ng/g)                                                     270   0.07--0.55     85.2                      0.4              0.4--0.5     \< LOD--6.3
   PCB-180 (ng/g)                                                     231   0.06--0.96     100                       1.5              1.4--1.7     0.3--30.0
   PCB-183 (ng/g)                                                     259   0.06--0.47     78.0                      0.3              0.3--0.4     \< LOD--8.2
   PCB-187 (ng/g)                                                     224   0.04--0.71     96.9                      0.9              0.8--1.0     \< LOD--38.3
   PCB-194 (ng/g)                                                     263   0.03--0.50     95.4                      0.5              0.5--0.6     \< LOD--8.6
   PCB-199 (ng/g)                                                     271   0.03--0.62     85.6                      0.4              0.3--0.4     \< LOD--7.5

Sum of all PCBs with a detection frequency ≥ 75% (listed above).

Enzyme inducers include PCBs 52, 99, 101, 118, 153, 156, 180, 183, 187, 194, and 199.

Mono-*ortho* PCBs include PCBs 28, 66, 74, 118, and 156.

Di-*ortho* PCBs include PCBs 18, 44, 49, 52, 99, 101, 138, 146, 153, 180, and 194.

Group 1 includes PCBs 44, 49, 52, 101, 187, and 199.

Group 2 includes PCBs 66, 74, 118, 138, and 156.

Group 3 includes PCBs 99, 153, 180, and 183.

###### 

Age-adjusted and fully adjusted associations between prenatal exposure to PCBs and neonatal TSH levels.

                                                                Age-adjusted   Fully adjusted [a](#tfn11-ehp0115-001490){ref-type="table-fn"}          
  ------------------------------------------------------------- -------------- ---------------------------------------------------------------- ------ ---------------
  ∑PCBs[b](#tfn12-ehp0115-001490){ref-type="table-fn"}          0.05           −0.05 to 0.15                                                    0.06   −0.05 to 0.16
  TEQ                                                           −0.01          −0.10 to 0.08                                                    0.00   −0.10 to 0.09
  Inducers[c](#tfn13-ehp0115-001490){ref-type="table-fn"}       0.09           −0.01 to 0.19                                                    0.11   0.01 to 0.21
  Mono-*ortho*[d](#tfn14-ehp0115-001490){ref-type="table-fn"}   0.01           −0.08 to 0.10                                                    0.01   −0.08 to 0.10
  Di-*ortho*[e](#tfn15-ehp0115-001490){ref-type="table-fn"}     0.08           −0.03 to 0.19                                                    0.09   −0.02 to 0.20
  Wolff method                                                                                                                                         
   Group 1[f](#tfn16-ehp0115-001490){ref-type="table-fn"}       0.05           −0.04 to 0.14                                                    0.06   −0.03 to 0.14
   Group 2[g](#tfn17-ehp0115-001490){ref-type="table-fn"}       0.04           −0.07 to 0.14                                                    0.05   −0.06 to 0.16
   Group 3[h](#tfn18-ehp0115-001490){ref-type="table-fn"}       0.09           0.00 to 0.18                                                     0.11   0.02 to 0.20
  Individual congeners                                                                                                                                 
   PCB-18                                                       0.03           −0.05 to 0.10                                                    0.03   −0.04 to 0.10
   PCB-28                                                       0.01           −0.06 to 0.08                                                    0.02   −0.06 to 0.08
   PCB-44                                                       0.03           −0.05 to 0.10                                                    0.03   −0.04 to 0.11
   PCB-49                                                       0.02           −0.06 to 0.09                                                    0.02   −0.05 to 0.09
   PCB-52                                                       0.03           −0.05 to 0.11                                                    0.03   −0.05 to 0.11
   PCB-66                                                       0.00           −0.08 to 0.08                                                    0.01   −0.07 to 0.09
   PCB-74                                                       0.03           −0.07 to 0.12                                                    0.03   −0.06 to 0.13
   PCB-99                                                       0.09           −0.00 to 0.18                                                    0.11   0.02 to 0.21
   PCB-101                                                      0.08           0.02 to 0.15                                                     0.09   0.03 to 0.16
   PCB-118                                                      0.01           −0.08 to 0.11                                                    0.03   −0.07 to 0.13
   PCB-138                                                      0.07           −0.01 to 0.15                                                    0.09   0.01 to 0.18
   PCB-146                                                      0.06           −0.02 to 0.14                                                    0.07   −0.01 to 0.15
   PCB-153                                                      0.07           −0.01 to 0.15                                                    0.08   0.00 to 0.17
   PCB-156                                                      0.04           −0.03 to 0.11                                                    0.05   −0.03 to 0.12
   PCB-180                                                      0.08           0.00 to 0.15                                                     0.09   0.01 to 0.17
   PCB-183                                                      0.12           0.05 to 0.19                                                     0.13   0.05 to 0.20
   PCB-187                                                      0.09           0.02 to 0.16                                                     0.09   0.02 to 0.17
   PCB-194                                                      0.11           0.03 to 0.19                                                     0.12   0.04 to 0.20
   PCB-199                                                      0.14           0.07 to 0.22                                                     0.14   0.07 to 0.22

Models adjusted for neonatal age at time of heel stick for TSH measurement, gestational age at birth, infant birth-weight, sex and mother's prepregancy BMI.

Sum of all PCBs with a detection frequency ≥ 75%.

Enzyme inducers include PCBs 52, 99, 101, 118, 153, 156, 180, 183, 187, 194, and 199.

Mono-*ortho* PCBs include PCBs 28, 66, 74, 118, and 156.

Di-*ortho* PCBs include PCBs 18, 44, 49, 52, 99, 101, 138, 146, 153, 180, and 194.

Group 1 includes PCBs 44, 49, 52, 101, 187, and 199.

Group 2 includes PCBs 66, 74, 118, 138, and 156.

Group 3 includes PCBs 99, 153, 180, and 183.
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